Return to List
Study Summary
No.
GS01-562:
.......
......
Barry Feig
......
Surgical Oncology
.
Study Summary Title
Study Summary
Number:
GS01-562
Study Title:
A Randomized Trial Evaluating the Use of Fibrin Tissue Adhesive Following Axillary Node Dissection in Patients with Breast Cancer
.
Physician
New Patient Referral
Name:
Barry Feig
Patients Call:
800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:
Surgical Oncology
Referring MD
Call:
800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:
713-794-1002
Contact us about clinical trials
.
General Information
Disease Group:
Supported By:
N/A
Phase of Study:
N/A
Return
Visit:
Follow-up wound examination will be performed by the local primary physician or
in the MDACC Breast Clinic between 1-3 weeks post-op and at approximately 6
weeks following surgery.
Treatment
Agents:
Home Care:
None
Treatment Loc:
Only at MDACC
Estimated
Length of Stay
in Houston:
Patients will be admitted for 23-hour observation.
Description/
Intervention:
The goal of this research study is to get information about participants'
experience with a surgical drain following an axillary nodal dissection.
.
Study Objectives / Outcomes
1.
Primary Objective
:
To determine whether the use of a fibrin sealant applied to axillary soft tissues following node dissection can result in earlier drain removal.
2.
Secondary Objectives
:
To determine the postoperative morbidity rate using fibrin sealant following axillary node dissection.
To assess patient-valuation of outcome by performing a cost-benefit analysis using a willingness-to-pay model.
.
Study Status Information
Study Activation / Registration Date:
02/25/2002
IRB Review and Approval Date:
11/07/2001
Study Type:
Therapeutic
Recruitment Status:
Terminated
Projected Accrual:
77
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you.
Please Contact the
Referral Office
for more information.
Inclusion Criteria:
Unavailable
Exclusion Criteria:
Unavailable
.
Links
Registration Number:
Not Applicable Clinical Trial
Other Links:
.
Results
Return to Clinical Trials at M.D. Anderson Cancer Center